Aluba, Emma .

HRN: 26-79-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
METRONIDAZOLE 500MG (TAB)
03/18/2025
03/24/2025
PO
500mg 2tabs
TID
Amoebiasis
Waiting Final Action 
03/22/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/22/2025
03/28/2025
IV
2.25g
Q8h
Acute Pyelonephritis
Waiting Final Action 
03/22/2025
METRONIDAZOLE 500MG (TAB)
03/22/2025
03/24/2025
PO
500mg
Q8h
Amoebiasis
Waiting Final Action 
03/22/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/22/2025
03/28/2025
IV
500mg
Q8h
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: